Recombinant Bacillus cereus Probable rRNA maturation factor (BCE_4383)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ybeY; BCE_4383; Endoribonuclease YbeY; EC 3.1.-.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-156
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus cereus (strain ATCC 10987 / NRS 248)
Target Names
ybeY
Target Protein Sequence
MSLLIDFIDE TEEVKEEYVN LIREILGKAA QMEKIEDGAE LSVTFVDNER IREINRDYRD KDQPTDVISF AMEEMGEGEM EIVGAEMPRM LGDLIISIPR AKEQAEEYGH SFDRELGFLA LHGFLHLLGY DHMTEEDEKE MFGRQKEILE AFGLGR
Uniprot No.

Target Background

Function
A single-strand-specific metallo-endoribonuclease involved in late-stage 70S ribosome quality control and 16S rRNA 3'-terminus maturation.
Database Links

KEGG: bca:BCE_4383

Protein Families
Endoribonuclease YbeY family
Subcellular Location
Cytoplasm.

Q&A

What is the biological role of the rRNA maturation factor (BCE_4383) in Bacillus cereus?

The BCE_4383 protein is a probable rRNA maturation factor that plays a critical role in ribosomal RNA processing and maturation in Bacillus cereus. As a member of the Bacillus cereus group, this organism contains various virulence factors and regulatory systems that may interact with or influence the function of BCE_4383 . The protein likely contributes to the organism's ability to adapt to various environmental conditions, similar to other regulatory proteins in the B. cereus group. The function of this protein must be understood within the context of B. cereus' lifecycle, which includes both vegetative growth and sporulation phases .

What are the optimal conditions for expressing recombinant BCE_4383 in E. coli systems?

For optimal expression of recombinant BCE_4383 in E. coli systems, researchers should consider the following protocol:

  • Vector selection: pET expression systems with T7 promoters typically yield high expression levels for Bacillus proteins.

  • E. coli strain: BL21(DE3) or Rosetta strains are recommended for enhanced expression of proteins with rare codons.

  • Induction parameters:

    • Temperature: 18-25°C for expression after induction (lower temperatures reduce inclusion body formation)

    • IPTG concentration: 0.1-0.5 mM

    • Duration: 16-18 hours for optimal protein folding

Based on protocols established for similar Bacillus proteins, transformation can follow standard methods similar to those used for B. cereus plasmid transformation, where approximately 1 μg of plasmid DNA is mixed with competent cells and subjected to electroporation (0.6 kV, 500 Ω, and 25 μF) . After expression, purification typically employs affinity chromatography followed by size exclusion methods to ensure protein integrity.

What CRISPR/Cas9 strategies can be employed to study BCE_4383 function in B. cereus?

CRISPR/Cas9 genome editing has proven highly effective for genetic manipulation in the Bacillus cereus group and can be applied to study BCE_4383 function through the following approach:

  • Design of sgRNA: Target sequences specific to BCE_4383 with minimal off-target effects, optimally 20 nucleotides in length with an adjacent PAM sequence (NGG).

  • Vector construction: Develop an all-in-one CRISPR-Cas9 plasmid containing:

    • Cas9 gene under mannose-inducible promoter

    • sgRNA expression cassette

    • Homologous arms (500-1000 bp each) flanking the target site for gene deletion or mutation

  • Transformation protocol:

    • Prepare electrocompetent B. cereus cells

    • Transform with 1 μg plasmid DNA

    • Pulse at 0.6 kV, 500 Ω, and 25 μF in a 0.1 cm gap cuvette

    • Immediately resuspend in 1 ml LB medium

    • Incubate for 1 hour at 30°C with shaking

    • Plate on selective media (kanamycin 25 μg/ml)

  • Induction and selection:

    • Grow transformants in liquid medium with kanamycin (25 μg/ml) for 3 hours at 30°C

    • Add mannose (0.4% final concentration) to induce Cas9 expression

    • Incubate for 13 hours at 28°C

    • Transfer to fresh medium and induce again

    • Plate dilutions and select edited clones

  • Verification: Confirm successful editing by PCR amplification and sequencing of the target region.

This method has demonstrated high efficiency in generating precise mutations in B. cereus genes, with success rates comparable to those achieved in B. anthracis genome modifications .

What considerations should be made when designing experiments to assess BCE_4383 interactions with ribosomes?

When designing experiments to assess BCE_4383 interactions with ribosomes, researchers should implement the following comprehensive approach:

  • Experimental design principles:

    • Employ a factorial design to systematically vary independent variables (protein concentration, salt conditions, temperature)

    • Include appropriate controls to account for non-specific binding

    • Ensure statistical power through adequate biological and technical replicates

  • In vitro binding assays:

    • Ribosome isolation: Purify intact ribosomes or ribosomal subunits from B. cereus using differential centrifugation

    • Protein labeling: Employ fluorescent tags or radioactive isotopes that minimally interfere with protein function

    • Binding conditions: Test multiple buffer compositions to identify optimal interaction conditions

    • Detection methods: Employ filter binding assays, surface plasmon resonance, or microscale thermophoresis for quantitative measurement

  • Structural analysis:

    • Cryo-EM studies of BCE_4383-ribosome complexes at various assembly stages

    • Hydrogen-deuterium exchange mass spectrometry to map interaction surfaces

    • Crosslinking followed by mass spectrometry to identify specific contact residues

  • Functional assays:

    • In vitro transcription-translation systems to assess the impact on protein synthesis

    • Ribosome assembly assays to determine the stage at which BCE_4383 acts

    • Competitive binding with known rRNA maturation factors to establish hierarchy

  • Data analysis strategy:

    • Determine binding kinetics parameters (Kd, kon, koff)

    • Apply statistical methods appropriate for multiple variable analysis

    • Use computational modeling to integrate experimental findings

How do mutations in BCE_4383 affect B. cereus virulence and pathogenicity?

Mutations in BCE_4383 may significantly impact B. cereus virulence through alterations in ribosome biogenesis and protein synthesis efficiency. A systematic approach to investigate this relationship would include:

  • Creation of mutant strains:

    • Generate point mutations or domain deletions using CRISPR/Cas9 genome editing

    • Develop complementation strains expressing wild-type BCE_4383 to verify phenotype rescue

    • Create reporter strains with fluorescently tagged virulence factors to monitor expression

  • Virulence factor expression analysis:

    • Quantify expression of key virulence factors such as phospholipase C, cereulide, and cytotoxin K

    • Monitor changes in hemolytic and phospholipase activities using plate assays similar to those employed for plcR mutants

    • Perform RNA-seq analysis to comprehensively assess transcriptome changes

  • Infection models:

    • Cellular models: Assess cytotoxicity against human epithelial cells and macrophages

    • Animal models: Evaluate bacterial load, dissemination, and host survival in appropriate models

    • Tissue-specific studies: Examine effects on pulmonary, ocular, or CNS infections based on B. cereus' known pathogenic profile

  • Comparative analysis with clinical isolates:

    • Sequence BCE_4383 in clinical isolates from various infection types

    • Correlate sequence variations with virulence phenotypes and clinical outcomes

    • Develop a predictive model of mutation impact on pathogenicity

B. cereus is known to cause various systemic and local infections, including fulminant bacteremia, CNS involvement, endophthalmitis, pneumonia, and cutaneous infections . Understanding how BCE_4383 mutations affect these pathogenic capabilities would provide valuable insights into B. cereus virulence mechanisms and potential therapeutic targets.

What role does BCE_4383 play in B. cereus stress response and adaptation?

The probable rRNA maturation factor BCE_4383 likely plays a crucial role in B. cereus adaptation to environmental stresses through modulation of ribosome assembly and function. To investigate this relationship:

  • Stress exposure studies:

    • Subject wild-type and BCE_4383 mutant strains to various stresses:

      • Heat shock (42-45°C)

      • Oxidative stress (H₂O₂, paraquat)

      • Antibiotic exposure (particularly those targeting translation)

      • Nutrient limitation

      • pH extremes

  • Quantitative assessment methods:

    • Growth kinetics analysis under various stress conditions

    • Measurement of survival rates following acute stress exposure

    • Determination of minimum inhibitory concentrations for various antibiotics

    • Assessment of spore formation efficiency and germination rates

  • Molecular response characterization:

    • Ribosome profiling to assess translation dynamics under stress

    • Quantification of rRNA processing intermediates

    • ChIP-seq analysis to identify stress-induced changes in BCE_4383 binding patterns

    • Protein-protein interaction studies to identify stress-specific binding partners

  • Transcriptional regulation:

    • Analyze BCE_4383 expression under different stress conditions

    • Identify transcription factors regulating BCE_4383 expression

    • Examine cross-talk with known stress response regulators

This approach would elucidate how BCE_4383 contributes to the remarkable adaptability of B. cereus to diverse environmental conditions and potentially explain its ubiquitous distribution in soil, food, and marine environments .

What is the relationship between BCE_4383 activity and sporulation in B. cereus?

The relationship between BCE_4383 activity and sporulation in B. cereus represents a critical aspect of this organism's lifecycle. To investigate this connection:

  • Temporal expression analysis:

    • Monitor BCE_4383 expression throughout the sporulation process using:

      • Transcriptomics (RNA-seq or qRT-PCR)

      • Western blotting with specific antibodies

      • Fluorescent protein fusions to track localization

  • Genetic manipulation approaches:

    • Create conditional BCE_4383 mutants using inducible promoters

    • Analyze sporulation efficiency in BCE_4383 deletion/depletion strains

    • Assess the impact of BCE_4383 overexpression on sporulation timing and efficiency

  • Microscopy-based assessment:

    • Employ phase-contrast microscopy to monitor morphological changes

    • Use fluorescence microscopy with membrane and DNA stains to track sporulation stages

    • Implement time-lapse microscopy to capture the entire sporulation process

  • Biochemical characterization:

    • Analyze rRNA processing patterns during sporulation in wild-type vs. mutant strains

    • Assess ribosome profiles during transition from vegetative growth to sporulation

    • Identify sporulation-specific interaction partners of BCE_4383

  • Comparative analysis with other Bacillus species:

    • Compare BCE_4383 function in B. cereus with homologs in B. anthracis and B. thuringiensis

    • Correlate differences in sporulation properties with BCE_4383 sequence variations

This investigation would provide insights into how BCE_4383 contributes to the sporulation process that is central to B. cereus persistence in diverse environments and its ability to cause food poisoning and other infections .

What are common challenges in purifying recombinant BCE_4383 and how can they be overcome?

Researchers frequently encounter several challenges when purifying recombinant BCE_4383. Here are systematic approaches to address these issues:

  • Poor solubility and inclusion body formation:

    • Solution: Optimize expression conditions by reducing temperature (16-20°C), lowering inducer concentration, and using slower induction

    • Alternative: Express as a fusion protein with solubility-enhancing tags (MBP, SUMO, or TrxA)

    • Recovery method: If inclusion bodies persist, develop a refolding protocol using step-wise dialysis with decreasing concentrations of chaotropic agents

  • Proteolytic degradation:

    • Solution: Add protease inhibitor cocktails during all purification steps

    • Alternative: Co-express with chaperones to enhance proper folding

    • Optimization: Identify and mutate protease-sensitive sites without affecting protein function

  • Co-purification of nucleic acids:

    • Solution: Increase salt concentration (up to 1M NaCl) in lysis and wash buffers

    • Treatment: Add nucleases (DNase I, RNase A) during initial purification steps

    • Validation: Monitor A260/A280 ratio to ensure protein purity

  • Loss of activity during purification:

    • Stabilization: Include specific cofactors or metal ions required for proper folding

    • Buffer optimization: Test various buffer compositions (HEPES, Tris, phosphate) and pH values

    • Storage: Determine optimal storage conditions (glycerol percentage, temperature, additives)

  • Purification troubleshooting table:

IssuePossible CauseSolutionValidation Method
Low yieldPoor expressionOptimize codon usage, change expression strainSDS-PAGE analysis
Multiple bandsDegradationAdd protease inhibitors, reduce purification timeWestern blot
Inactive proteinImproper foldingInclude chaperones, optimize refoldingActivity assay
AggregationHydrophobic interactionsAdd mild detergents, increase saltDynamic light scattering
ContaminantsNon-specific bindingIncrease imidazole in wash buffersMass spectrometry

These methodological approaches are based on established protocols for purifying recombinant proteins from Bacillus species and can be adapted specifically for BCE_4383 based on its unique characteristics.

How can researchers distinguish between the effects of BCE_4383 mutation and polar effects on adjacent genes?

Distinguishing between direct effects of BCE_4383 mutation and polar effects on adjacent genes requires a systematic experimental approach:

  • Complementation strategies:

    • In trans complementation: Introduce wild-type BCE_4383 on a plasmid under native or inducible promoter

    • Chromosomal complementation: Reintroduce BCE_4383 at a neutral site in the chromosome

    • Dose-dependent complementation: Use various promoter strengths to assess the relationship between BCE_4383 expression levels and phenotype restoration

  • Targeted mutagenesis approaches:

    • Silent mutations: Introduce synonymous mutations that maintain protein sequence while altering nucleotide sequence

    • Domain-specific mutations: Target specific functional domains rather than creating complete gene deletions

    • CRISPR interference (CRISPRi): Use catalytically inactive Cas9 for targeted gene repression without genomic alterations

  • Transcriptional analysis:

    • Strand-specific RNA-seq: Assess impact on adjacent gene expression

    • qRT-PCR validation: Quantify expression changes in genes upstream and downstream

    • Promoter fusion studies: Create transcriptional fusions to report on promoter activity

  • Operon structure analysis:

    • 5' RACE: Define transcriptional start sites of adjacent genes

    • RT-PCR spanning gene junctions: Determine if BCE_4383 is part of an operon

    • Northern blot analysis: Identify transcript sizes to determine co-transcription

The CRISPR/Cas9 system described for B. cereus can be particularly useful here, as it allows for precise genome editing with minimal disruption to surrounding sequences . By designing homologous arms that precisely delete only the target gene while maintaining the integrity of adjacent regulatory sequences, researchers can minimize polar effects and create clean deletions for phenotypic analysis.

What strategies can be employed to overcome challenges in crystallizing BCE_4383 for structural studies?

Crystallizing BCE_4383 for structural studies presents several challenges that can be addressed through the following systematic approaches:

  • Protein sample optimization:

    • Construct design: Create multiple constructs with different N- and C-terminal boundaries to remove flexible regions

    • Surface engineering: Introduce surface entropy reduction mutations (replacing clusters of high-entropy residues like Lys, Glu, and Gln with alanines)

    • Fusion partners: Utilize crystallization chaperones such as T4 lysozyme, MBP, or BRIL to provide crystal contacts

  • Crystallization condition screening:

    • Initial screening: Employ sparse matrix screens covering diverse precipitants, buffers, and additives

    • Grid screening: Optimize promising conditions by systematically varying pH, precipitant concentration, and temperature

    • Microseeding: Introduce crystal seeds into fresh drops to promote nucleation and growth

    • Alternative approaches: Consider counter-diffusion, batch, or dialysis methods if vapor diffusion is unsuccessful

  • Complex formation strategies:

    • Ligand co-crystallization: Include substrate analogs, inhibitors, or binding partners

    • Stabilizing agents: Add small molecules that enhance conformational stability

    • Metal ions: Screen various metal ions that might be critical for structural integrity

  • Alternative structural approaches:

    • Cryo-electron microscopy: For BCE_4383-ribosome complexes or if crystal formation remains challenging

    • NMR spectroscopy: For structural analysis of isolated domains

    • Small-angle X-ray scattering (SAXS): For low-resolution envelope determination and conformational dynamics

  • Crystallization optimization table:

ParameterVariation RangeOptimization Strategy
Protein concentration2-20 mg/mlSystematic screening with 2 mg/ml increments
Temperature4°C, 16°C, 20°CParallel trials at different temperatures
Precipitant concentration50-150% of initial hitFine gradient around promising conditions
Additive screeningDetergents, alcohols, polyaminesSupplement base conditions with commercial additive screens
Drop ratio (protein:reservoir)1:1, 1:2, 2:1Vary drop composition to alter equilibration rate

These approaches have proven successful for crystallizing challenging bacterial proteins, including those involved in RNA processing and maturation.

How might high-throughput screening approaches be used to identify inhibitors of BCE_4383 as potential antimicrobial agents?

High-throughput screening (HTS) approaches for identifying BCE_4383 inhibitors as potential antimicrobial agents could follow this comprehensive workflow:

  • Assay development and validation:

    • Primary assay: Develop a fluorescence-based or bioluminescent assay measuring BCE_4383 activity on model RNA substrates

    • Counter-screening: Establish assays to eliminate compounds that non-specifically interfere with RNA or general RNA-binding proteins

    • Validation criteria: Z' factor > 0.5, signal-to-background ratio > 10, coefficient of variation < 10%

  • Compound library selection:

    • Diverse chemical libraries: Begin with 50,000-100,000 compounds covering broad chemical space

    • Focused libraries: Include known RNA-binding compounds, nucleoside analogs, and antimicrobials

    • Natural product extracts: Screen fractionated extracts from microorganisms and plants

  • Screening cascade:

    • Primary screen: Test compounds at a single concentration (10-20 μM)

    • Dose-response confirmation: Generate full dose-response curves for hits (IC₅₀ determination)

    • Secondary assays: Validate hits in orthogonal biochemical assays

    • Cellular validation: Assess antimicrobial activity against B. cereus and related pathogens

  • Hit-to-lead optimization:

    • Structure-activity relationship studies: Synthesize analogs to improve potency and selectivity

    • Mode of action studies: Determine binding site through mutagenesis and structural studies

    • ADME-Tox assessment: Evaluate drug-like properties and potential toxicity

    • In vivo efficacy: Test lead compounds in relevant infection models

  • Key success criteria for inhibitor development:

ParameterThreshold for ProgressionMethod of Determination
BCE_4383 inhibitionIC₅₀ < 1 μMEnzymatic assay
Antimicrobial activityMIC < 8 μg/ml against B. cereusBroth microdilution
Selectivity>50-fold vs. human homologsComparative biochemical assays
CytotoxicityCC₅₀ > 50 μM in mammalian cellsMTT or similar viability assay
Solubility>100 μM in aqueous solutionKinetic solubility assay

Given B. cereus' role as a significant human pathogen causing food poisoning, systemic infections, and even anthrax-like progressive pneumonia , developing specific inhibitors targeting BCE_4383 could provide valuable new therapeutic approaches, especially for infections resistant to conventional antibiotics.

What insights could comparative genomics provide about the evolution of BCE_4383 across the Bacillus cereus group?

Comparative genomics approaches can provide significant insights into the evolution of BCE_4383 across the Bacillus cereus group through the following multifaceted analysis:

  • Phylogenetic analysis:

    • Sequence alignment: Construct multiple sequence alignments of BCE_4383 homologs from all sequenced B. cereus group species

    • Tree construction: Generate phylogenetic trees using maximum likelihood and Bayesian methods

    • Evolutionary rate analysis: Calculate dN/dS ratios to identify sites under positive or purifying selection

  • Structural conservation assessment:

    • Domain architecture: Identify conserved and variable domains across species

    • Functional site prediction: Map conserved residues onto structural models

    • Comparative structural modeling: Generate models for BCE_4383 variants across species

  • Genomic context analysis:

    • Synteny mapping: Examine conservation of gene neighborhoods around BCE_4383

    • Operon structure comparison: Determine if operon organization varies between species

    • Mobile genetic element association: Identify any association with transposons, phages, or other mobile elements

  • Functional divergence investigation:

    • Expression pattern comparison: Analyze transcriptomic data across species under various conditions

    • Regulatory element identification: Compare promoter regions and transcription factor binding sites

    • Post-translational modification prediction: Identify potential species-specific modifications

  • Ecological and pathogenic correlation:

    • Niche adaptation: Correlate BCE_4383 sequence variations with ecological niches

    • Virulence association: Examine relationships between BCE_4383 variants and pathogenic potential

    • Host range determination: Assess if BCE_4383 variations correlate with host specificity

This comparative approach would be particularly informative given the close genetic relationship but distinct ecological and pathogenic characteristics of the B. cereus group members, which includes the highly pathogenic B. anthracis alongside less virulent strains . Understanding the evolution of BCE_4383 could provide insights into how rRNA processing machinery has adapted across this diverse bacterial group and potentially reveal novel targets for species-specific interventions.

How can researchers effectively collaborate on BCE_4383 studies across different specialties and institutions?

Effective collaboration on BCE_4383 studies across specialties and institutions requires a structured approach:

  • Interdisciplinary research framework:

    • Core expertise integration: Combine molecular biologists, structural biologists, microbiologists, and bioinformaticians

    • Technology platform sharing: Establish protocols for sharing specialized equipment and methodologies

    • Complementary skill mapping: Identify unique capabilities at each institution to maximize resource utilization

  • Standardized protocols and data sharing:

    • Method harmonization: Develop and validate consistent experimental protocols across sites

    • Data repository: Establish a centralized database for raw data, results, and analyses

    • Material exchange: Create a standardized system for sharing strains, plasmids, and reagents

  • Communication infrastructure:

    • Regular virtual meetings: Schedule recurring video conferences with defined agendas

    • Progress tracking system: Implement project management software to monitor milestones

    • Real-time collaboration tools: Utilize electronic lab notebooks and collaborative document platforms

  • Integrated experimental design:

    • Design of experiments approach: Apply factorial experimental design to systematically address complex questions

    • Sequential validation: Design studies where results from one institution inform experiments at another

    • Complementary methodologies: Apply different techniques to answer the same research question

  • Collaborative publication strategy:

    • Authorship guidelines: Establish clear criteria for authorship and author order

    • Manuscript development workflow: Create a structured process for manuscript preparation with defined responsibilities

    • Preprint sharing: Utilize preprint servers to gather community feedback before formal submission

This collaborative framework would be particularly valuable for BCE_4383 research given the multifaceted nature of rRNA maturation factors and the diverse techniques required to fully characterize their function, from genomic manipulation using CRISPR/Cas9 systems to structural and biochemical analyses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.